Nasonex Nasal Spray

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved January 1999

Specific Treatments:

Immunology/Allergy

Find Related Trials for The Following Conditions

General Information

Nasonex has been approved for the prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis and the treatment of the nasal symptoms of perennial allergic rhinitis, in adults and children 12 years of age and older.